Vice versa, direct occlusion of the superior mesenteric vessels, vein, artery, or vein and artery (i.e., portal, caval hypertension, aortal hypotension, peripheral lesions) rapidly induced the intracranial (superior sagittal sinus) hypertension, brain swelling, and lesions [14,15,16]
The weight loss, frequency of administration, low risk of hypoglycemia, and mechanism of controlling prandial blood glucose seen with GLP-1 RAs offer many advantages as an alternative to prandial insulin
[1] U.S
The clinical evidence behind them is unusually strong: in large randomized trials, semaglutide produced about 14.9% mean weight loss over 68 weeks and high-dose tirzepatide up to about 20.9% over 72 weeks
A Glimpse Into the Future The integration of pharmaceutical advances like GLP-1 receptor agonists and innovative monitoring technologies like Wesper heralds a new era in sleep medicine